ID
20975
Beschrijving
Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423); ODM derived from: https://clinicaltrials.gov/show/NCT00724893
Link
https://clinicaltrials.gov/show/NCT00724893
Trefwoorden
Versies (1)
- 01-04-17 01-04-17 -
Geüploaded op
1 april 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatitis C, Chronic NCT00724893
Eligibility Hepatitis C, Chronic NCT00724893
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Hepatitis B | Hepatitis B surface antigen positive
Datatype
boolean
Alias
- UMLS CUI [1]
- C0019163
- UMLS CUI [2]
- C0149709
Beschrijving
HIV antibody positive
Datatype
boolean
Alias
- UMLS CUI [1]
- C0920548
Beschrijving
Transplantation of liver Status post
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0023911
- UMLS CUI [1,2]
- C0231290
Beschrijving
Exclusion Criteria Pharmaceutical Product Information
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C1709517
Similar models
Eligibility Hepatitis C, Chronic NCT00724893
- StudyEvent: Eligibility
C0524910 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
C0278329 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C3714738 (UMLS CUI [1,3])
C0013227 (UMLS CUI [1,2])
C0149709 (UMLS CUI [2])
C0231290 (UMLS CUI [1,2])
C1709517 (UMLS CUI [1,2])